000			01520 a2200421 4500
005			20250517043503.0
264		0	_c20160505
008			201605s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0133735 _2doi
040			_aNLM _beng _cNLM
100	1		_aSrivastava, Gunjan
245	0	0	_aAnticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy. _h[electronic resource]
260			_bPloS one _c2015
300			_ae0133735 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnnexin A5 _xmetabolism
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAziridines _xadministration & dosage
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHumans
650	0	4	_aIndolequinones _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMouth Neoplasms _xdrug therapy
650	0	4	_aTumor Burden
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aSomasundaram, Raj Thani
700	1		_aWalfish, Paul G
700	1		_aRalhan, Ranju
773	0		_tPloS one _gvol. 10 _gno. 7 _gp. e0133735
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0133735 _zAvailable from publisher's website
999			_c25106643 _d25106643